These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3155649)
21. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695 [TBL] [Abstract][Full Text] [Related]
22. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer. Gu Y; Shu Y; Xu Q Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761 [TBL] [Abstract][Full Text] [Related]
23. Treatment of colorectal cancer and other malignancies with continuous infusion of 5-fluorouracil. Barbounis VP; Kalofonos HP; Munro AJ; McKenzie CG; Sackier JM; Epenetos AA Anticancer Res; 1989; 9(1):33-9. PubMed ID: 2705753 [TBL] [Abstract][Full Text] [Related]
24. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207 [TBL] [Abstract][Full Text] [Related]
26. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors. Bhalla KN; Kumar GN; Walle UK; Ibrado AM; Javed T; Stuart RK; Reed C; Arbuck SG; Walle T Clin Cancer Res; 1999 Jul; 5(7):1723-30. PubMed ID: 10430075 [TBL] [Abstract][Full Text] [Related]
28. Long-term, ambulatory, continuous intravenous infusion of 5-fluorouracil for the treatment of metastatic adenocarcinoma in the liver. Ausman RK; Caballero GA; Quebbeman E; Ausman DC Wis Med J; 1982 Mar; 81(3):25-8. PubMed ID: 7090413 [No Abstract] [Full Text] [Related]
29. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. Hartmann JT; Kanz L; Bokemeyer C Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418 [TBL] [Abstract][Full Text] [Related]
30. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers. Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794 [TBL] [Abstract][Full Text] [Related]
39. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Hansen R; Quebbeman E; Beatty P; Ritch P; Anderson T; Jenkins D; Frick J; Ausman R Breast Cancer Res Treat; 1987 Nov; 10(2):145-9. PubMed ID: 3427223 [TBL] [Abstract][Full Text] [Related]
40. Tolerance of extended (28 day) continuous infusion of 5-fluorouracil in advanced head and neck cancer. Grunberg SM; Clay C; Spicer DV Sel Cancer Ther; 1991; 7(1):17-21. PubMed ID: 1833803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]